This report comes with 10% free customization, enabling you to add data that meets your specific business needs.
1h Free Analyst TimeSpeak directly to the analyst to clarify any post sales queries you may have.
Surgeons and healthcare institutions in the region are leveraging robotic-assisted surgery for a spectrum of medical specialties, ranging from urology and gynaecology to orthopaedics and neurosurgery. Furthermore, around 1,500 da Vinci systems have been deployed throughout Europe since the first robotically assisted da Vinci prostatectomy was carried out in Germany almost 20 years ago, demonstrating the continent's great demand for this cutting-edge technology. Surgical robots in Europe are widely used across various medical specialties, including urology, gynaecology, orthopaedics, neurosurgery, and general surgery. The versatility of these systems allows for a broad range of applications.
European healthcare systems are actively involved in training and educating surgeons and medical staff in the use of surgical robots. Training programmes and workshops contribute to the widespread adoption and effective utilisation of these advanced technologies. Furthermore, economic factors, including healthcare budgets and cost considerations, impact the adoption of surgical robots. Efforts are made to demonstrate the long-term economic benefits, such as reduced hospital stays and improved efficiency.
According to the research report, 'Europe Surgical Robot Market Outlook, 2029', the Europe Surgical Robot market is projected to reach a market size of more than USD 4 Billion by 2029. The European surgical robot market has experienced significant growth in recent years, with the market size expanding as robotic technologies become more integrated into surgical procedures across the continent. European healthcare institutions have increasingly embraced the trend towards minimally invasive surgery.
Surgical robots play a pivotal role in facilitating minimally invasive procedures, leading to benefits such as reduced trauma, shorter recovery times, and improved patient outcomes. The European surgical robot market is characterised by continuous technological advancements. Ongoing innovations include improvements in robotic arms, enhanced imaging capabilities, and the development of more intuitive and user-friendly interfaces for surgeons. The European surgical robot market is characterised by a strong emphasis on improving patient outcomes.
The integration of robotic technologies is often driven by the desire to enhance surgical precision, reduce complications, and optimize recovery for patients. There is variation in the adoption of surgical robots across European countries, influenced by differences in healthcare infrastructure, financial considerations, and regulatory environments.
Market Drivers
- Minimally Invasive Surgery (MIS) Trends: The rising preference for minimally invasive surgical procedures is a major driver. Surgical robots enable precise and controlled movements in confined spaces, facilitating complex surgeries with smaller incisions, reduced scarring, and quicker recovery times.
- Positive Patient Outcomes and Safety: The focus on achieving positive clinical outcomes and ensuring patient safety is a key driver. Surgical robots can contribute to reduced complications, shorter hospital stays, and overall improved patient satisfaction.
- Economic Considerations and Efficiency: While there are upfront costs associated with acquiring and maintaining surgical robots, the potential economic benefits drive adoption. The efficiency gained in terms of shorter procedure times and reduced postoperative care costs can make robotic-assisted surgery economically viable.
Market Challenges
- Cost of Maintenance and Upgrades: Beyond the initial purchase, the maintenance costs and expenses associated with software upgrades can be significant. Healthcare providers need to consider the total cost of ownership over the lifespan of the robotic systems.
- Complex Regulatory Environment: Adhering to diverse and complex regulatory requirements across European countries poses a challenge for manufacturers and healthcare institutions. Harmonising regulations for medical devices, including surgical robots, can streamline adoption.
Market Opportunity
- Expansion of Indications and Specialties: The opportunity to expand the indications and specialties for robotic-assisted surgery is substantial. Continued research and development can open up new possibilities, allowing surgical robots to be applied to a broader range of medical procedures.
- Teleoperation and Remote Surgery: The development of teleoperation capabilities for surgical robots presents opportunities for remote surgery. This can improve access to specialised surgical expertise, particularly in regions with limited resources or during emergency situations.
Laparoscopic robotic systems have undergone regulatory scrutiny and received approvals, contributing to their widespread use. The standardisation of practices and regulations within the European region further supports their adoption. Laparoscopic robotic systems, while still requiring a significant investment, are perceived as more economically viable compared to some other specialised robotic systems. Hospitals and healthcare providers consider the cost-effectiveness of adopting these technologies. Ongoing research and development efforts in the field of laparoscopic robotic surgery drive innovation.
Manufacturers focus on improving system capabilities, developing more intuitive interfaces, and advancing instrumentation for laparoscopic procedures. Laparoscopic robotic systems have been in use for a longer period of time, contributing to their market maturity and acceptance among surgeons. Surgeons familiar with robotic-assisted laparoscopic techniques are more inclined to continue using these systems. Furthermore, surgical systems contribute to the market, and the growing trend towards minimally invasive surgery (MIS) is a significant driver. Surgical robotic systems enable precise and controlled movements in confined spaces, facilitating complex procedures through smaller incisions.
This trend aligns with the emphasis on reducing patient trauma and improving recovery times. Surgical robotic systems are versatile and applicable to various medical specialties, such as urology, gynaecology, orthopaedics, and general surgery. The adaptability of these systems makes them suitable for a wide range of procedures, contributing to their widespread use. While there is an initial investment cost associated with acquiring and maintaining surgical robotic systems, the potential economic benefits contribute to their growth. Hospitals and healthcare providers evaluate the long-term cost-effectiveness and improved efficiency offered by these systems.
According to the report, the major applications are segmented into orthopaedic surgery, gynaecological surgery, general surgery, urological surgery, neurosurgery, and other applications. In Europe, neurosurgery contributes to the market. The market is divided into two segments based on the end user: hospitals and clinics and ambulatory surgery centres. In Europe, hospitals and clinics dominate the market.
Surgical robots in neurosurgery typically come equipped with advanced imaging and visualisation technologies. This enhanced visualisation allows surgeons to navigate and operate in complex anatomical structures with improved clarity, reducing the risk of damage to surrounding tissues. In Europe, surgical robots used in neurosurgery often have microsurgery capabilities, allowing surgeons to perform highly detailed and delicate procedures. This is particularly important in cases where the manipulation of small structures, such as blood vessels or nerves, is necessary.
The integration of surgical robots in neurosurgery requires specialised training for surgeons. Training programmes help neurosurgeons develop the skills needed to operate robotic systems effectively, contributing to the overall growth of expertise in the field. Furthermore, hospitals and clinics lead the surgical robot market. Hospitals and clinics in Europe typically boast advanced healthcare infrastructure. These institutions are well-equipped to integrate cutting-edge technologies, including surgical robots, into their existing facilities.
The focus on patient-centric care drives healthcare providers to adopt technologies that offer improved outcomes and enhanced patient experiences. Surgical robots contribute to minimally invasive procedures, reducing patient trauma and promoting faster recovery, aligning with patient-centric care models. Hospitals and clinics aim to differentiate themselves in a competitive healthcare landscape. Adopting advanced technologies such as surgical robots can be a strategic differentiator, attracting both patients and skilled healthcare professionals.
According to the report, the major countries covered in the report include Germany, the United Kingdom, France, Italy, Spain, Russia, and the rest of Europe.
In Europe, Germany contributes the highest market share. Germany boasts a well-developed and advanced healthcare infrastructure. The country's hospitals and clinics are equipped with state-of-the-art facilities, making it conducive to the integration of cutting-edge technologies like surgical robots. Germany is known for its strong emphasis on research and development (R&D) in various industries, including healthcare. The country has a robust ecosystem that fosters innovation and contributes to the development of advanced medical technologies, including surgical robots.
Germany has a thriving medical device industry with a focus on innovation and manufacturing. The presence of leading medical device companies, including those specialising in surgical robotics, contributes to the country's leadership in adopting and promoting these technologies. The country's healthcare system emphasises comprehensive training for healthcare professionals, including surgeons. Well-trained and skilled surgeons are more likely to adopt and utilise surgical robots effectively, contributing to the technology's success in the market.
Germany's economic strength and financial capacity enable hospitals and healthcare institutions to make significant investments in advanced medical technologies. The availability of financial resources supports the adoption of surgical robots, which can initially involve substantial upfront costs. Germany has a robust regulatory framework for medical devices, ensuring that new technologies, including surgical robots, adhere to high safety and quality standards. A clear regulatory environment facilitates the approval and integration of these technologies into clinical practice.
Key companies are increasingly focusing on introducing innovative technologies and entering into various strategic collaborations with orthopedic centers & other industry players to acquire new capabilities in surgical robots to maintain their competitive edge. Companies are also undertaking other strategies, such as new product launches and collaborations & partnerships. Moreover, rising demand for automated surgical instruments globally is likely to promote the entry of new companies into the market. Furthermore, these companies plan to expand their robotic systems' applications to include spine, shoulder, and other surgical procedures in the near future.
The global market for surgical robots is mainly concentrated in developed regions such as North America, Europe, and Asia Pacific. The market is expected to grow significantly in the coming years, driven by increasing awareness of the disease, advancements in treatment options, and rising prevalence. North America is the leading market for surgical robots, with the United States playing a major role in its growth.
Considered in this report
- Historic year: 2018
- Base year: 2023
- Estimated year: 2024
- Forecast year: 2029
Aspects covered in this report
- Surgical Robots market Outlook with its value and forecast along with its segments
- Various drivers and challenges
- On-going trends and developments
- Top profiled companies
- Strategic recommendation
By Surgical Robot Function
- Laparoscopic robots
- Endoscopic robots
- Microsurgical robots
- Robot-assisted radiosurgery
- Rehabilitation robots
- Telepresence robots
By Product & Services
- Instrument & Accessories
- Surgical systems
- Services (Maintenance & Up gradation)
By Application
- Orthopetical Surgery
- Gynecological Surgery
- General Surgery
- Urological Surgery
- Neurosurgery
- Other Applications
By End Use
- Hospitals & Clinics
- Ambulatory Surgery Centers
- Refrigerated Transportation
The approach of the report:
This report consists of a combined approach of primary and secondary research. Initially, secondary research was used to get an understanding of the market and list the companies that are present in it. The secondary research consists of third-party sources such as press releases, annual reports of companies, and government-generated reports and databases. After gathering the data from secondary sources, primary research was conducted by conducting telephone interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this; we have started making primary calls to consumers by equally segmenting them in regional aspects, tier aspects, age group, and gender. Once we have primary data with us, we can start verifying the details obtained from secondary sources.Intended audience
This report can be useful to industry consultants, manufacturers, suppliers, associations, and organizations related to the Surgical Robots industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing and presentations, it will also increase competitive knowledge about the industry.This product will be delivered within 2 business days.
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Stryker Corporation
- Medtronic plc
- Smith & Nephew plc
- Siemens Healthineers
- Zimmer Biomet Holdings Inc
- Renishaw plc
- CMR Surgical
- Intuitive Surgical Inc
- Accuray Incorporated
- Johnson & Johnson
- Becton Dickinson and Company
- Brainlab